| Line Item | 2025-11-01 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $472.5M | +3.9% | +150.7% |
| Cost of Revenue | $368.4M | +2.5% | +220.9% |
| Gross Profit | $104.1M | +9.4% | +41.4% |
| R&D Expense | $36.0M | +8.7% | +25.3% |
| SG&A Expense | $98.3M | -25.1% | +159.4% |
| Operating Income | -$30.2M | +56.4% | -531.4% |
| Pre-tax Income | -$20.6M | +75.6% | -425.4% |
| Income Tax | -$2.3M | +84.8% | -943.0% |
| Net Income | -$17.1M | +74.6% | -326.7% |
| EPS (Basic) | -$0.34 | +76.4% | -225.9% |
| EPS (Diluted) | -$0.34 | +76.4% | -225.9% |
| Line Item | 2025-11-01 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $359.4M | -47.6% | +421.2% |
| Short-term Investments | $229.0M | — | — |
| Accounts Receivable | $232.3M | +17.2% | +214.3% |
| Inventory | $259.2M | +11.3% | +85.6% |
| Current Assets | $1.67B | +1.7% | +223.7% |
| Total Assets | $5.64B |
| Line Item | 2025-11-01 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$168.8M | -36.4% | — |
| Capital Expenditures | $33.5M | +47.6% | — |
| Investing Cash Flow | -$1.16B | -32.1% | — |
| Financing Cash Flow | $1.65B | -0.0% | — |
| Free Cash Flow | -$202.3M | -38.2% | — |
| +453.3% |
| Current Liabilities | $328.0M | +19.3% | +193.9% |
| Long-term Debt | $747.5M | +0.0% | +4883.3% |
| Stockholders' Equity | $4.42B | -0.2% | +414.7% |